HCA Healthcare (HCA) Coverage Initiated at Barclays

Investment analysts at Barclays initiated coverage on shares of HCA Healthcare (NYSE:HCA) in a report issued on Tuesday, The Fly reports. The brokerage set an “overweight” rating on the stock.

A number of other equities analysts have also recently weighed in on the company. Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “sell” rating in a research note on Tuesday, April 17th. SunTrust Banks reissued a “buy” rating and issued a $125.00 price target on shares of HCA Healthcare in a research note on Friday, July 20th. Morgan Stanley lifted their price target on HCA Healthcare from $91.00 to $98.00 and gave the stock an “underweight” rating in a research note on Friday, July 13th. Credit Suisse Group lifted their price target on HCA Healthcare from $122.00 to $143.00 and gave the stock an “outperform” rating in a research note on Friday, July 27th. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $124.00 price target on shares of HCA Healthcare in a research note on Thursday, July 26th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $117.40.

Shares of HCA opened at $128.65 on Tuesday. The stock has a market capitalization of $44.35 billion, a P/E ratio of 19.52, a P/E/G ratio of 1.16 and a beta of 0.53. HCA Healthcare has a 1-year low of $71.18 and a 1-year high of $131.10. The company has a debt-to-equity ratio of -7.64, a quick ratio of 1.15 and a current ratio of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.16 by $0.13. The firm had revenue of $11.53 billion for the quarter, compared to analysts’ expectations of $11.32 billion. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. HCA Healthcare’s revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the business posted $1.73 EPS. equities analysts forecast that HCA Healthcare will post 9.23 EPS for the current year.

In other news, insider Charles J. Hall sold 34,125 shares of HCA Healthcare stock in a transaction dated Friday, August 3rd. The stock was sold at an average price of $129.93, for a total transaction of $4,433,861.25. Following the completion of the sale, the insider now directly owns 98,124 shares in the company, valued at approximately $12,749,251.32. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CMO Jonathan B. Perlin sold 10,000 shares of HCA Healthcare stock in a transaction dated Wednesday, July 25th. The shares were sold at an average price of $112.53, for a total value of $1,125,300.00. Following the sale, the chief marketing officer now owns 105,394 shares of the company’s stock, valued at $11,859,986.82. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 215,688 shares of company stock worth $25,779,901. Company insiders own 2.80% of the company’s stock.

Several institutional investors have recently made changes to their positions in HCA. Smithfield Trust Co. lifted its holdings in HCA Healthcare by 541.9% in the 2nd quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock worth $102,000 after purchasing an additional 840 shares during the last quarter. NN Investment Partners Holdings N.V. lifted its holdings in HCA Healthcare by 198.9% in the 2nd quarter. NN Investment Partners Holdings N.V. now owns 170,204 shares of the company’s stock worth $17,463,000 after purchasing an additional 113,265 shares during the last quarter. CWM Advisors LLC acquired a new stake in HCA Healthcare in the 2nd quarter worth approximately $338,000. James Investment Research Inc. lifted its holdings in HCA Healthcare by 3.6% in the 2nd quarter. James Investment Research Inc. now owns 20,825 shares of the company’s stock worth $2,137,000 after purchasing an additional 725 shares during the last quarter. Finally, Pinnacle Financial Partners Inc. lifted its holdings in HCA Healthcare by 4.0% in the 2nd quarter. Pinnacle Financial Partners Inc. now owns 90,494 shares of the company’s stock worth $9,285,000 after purchasing an additional 3,457 shares during the last quarter. Institutional investors and hedge funds own 71.84% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Google Finance

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply